17β-Estradiol reduces inflammation and modulates antioxidant enzymes in colonic epithelial cells
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Estrogen is known to have protective effect in colorectal cancer development. The aims of this study are to investigate whether estradiol treatment reduces inflammation in CCD841CoN, a female human colonic epithelial cell line and to uncover underlying mechanisms of estradiol effects. Methods: 17β-Estradiol (E2) effect was measured by Western blot after inducing inf lammation of CCD841CoN by tumor necrosis factor α (TNF-α). Expression levels of estrogen receptor α (ERα) and β (ERβ), cyclooxygenase-2 (COX-2), nuclear factor-κB (NF-κB), heme oxygenase-1 (HO-1), and NAD(P)H-quinone oxidoreductase- 1 (NQO-1) were also evaluated. Results: E2 treatment induced expression of ERβ but did not increase that of ERα. E2 treatment for 48 hours significantly elevated the expression of anti-oxidant enzymes, HO-1 and NQO-1. TNF-α treatment significantly increased the level of activated NF-κB (p < 0.05), and this increase was significantly suppressed by treatment of 10 nM of E2 (p < 0.05). E2 treatment ameliorated TNF-α-induced COX-2 expression and decrease of HO-1 expression. 4-(2-phenyl-5,7-bis(trifluoromethyl) pyrazolo(1,5-a)pyrimidin-3-yl)phenol (PHTPP), antagonist of ERβ, removed the inhibitory effect of E2 in the TNF-α-induced COX-2 expression (p = 0.05). Conclusions: Estrogen seems to inhibit inflammation in female human colonic epithelial cell lines, through down-regulation of NF-κB and COX-2 expression and induction of anti-oxidant enzymes such as HO-1 and NQO-1.
Abstract
Background/Aims: Estrogen is known to have protective effect in colorectal cancer development. The aims of this study are to investigate whether estradiol treatment reduces inflammation in CCD841CoN, a female human colonic epithelial cell line and to uncover underlying mechanisms of estradiol effects. Methods: 17β-Estradiol (E2) effect was measured by Western blot after inducing inf lammation of CCD841CoN by tumor necrosis factor α (TNF-α). Expression levels of estrogen receptor α (ERα) and β (ERβ), cyclooxygenase-2 (COX-2), nuclear factor-κB (NF-κB), heme oxygenase-1 (HO-1), and NAD(P)H-quinone oxidoreductase- 1 (NQO-1) were also evaluated. Results: E2 treatment induced expression of ERβ but did not increase that of ERα. E2 treatment for 48 hours significantly elevated the expression of anti-oxidant enzymes, HO-1 and NQO-1. TNF-α treatment significantly increased the level of activated NF-κB (p < 0.05), and this increase was significantly suppressed by treatment of 10 nM of E2 (p < 0.05). E2 treatment ameliorated TNF-α-induced COX-2 expression and decrease of HO-1 expression. 4-(2-phenyl-5,7-bis(trifluoromethyl) pyrazolo(1,5-a)pyrimidin-3-yl)phenol (PHTPP), antagonist of ERβ, removed the inhibitory effect of E2 in the TNF-α-induced COX-2 expression (p = 0.05). Conclusions: Estrogen seems to inhibit inflammation in female human colonic epithelial cell lines, through down-regulation of NF-κB and COX-2 expression and induction of anti-oxidant enzymes such as HO-1 and NQO-1.
참고문헌 (35)
- Mantovani A, "Cancer-related inflammation", Nature, 454, pp.436~444 (2008)
- Koehne CH, "COX-2 inhibition and colorectal cancer", Semin Oncol, 31(2 Suppl 7), pp.12~21 (2004)
- Chan AT, "Aspirin and the risk of colorectal cancer in relation to the expression of COX-2", N Engl J Med, 356, pp.2131~2142 (2007)
- Wang D, "The role of COX-2 in intestinal inflammation and colorectal cancer", Oncogene, 29, pp.781~788 (2010)
- Sun Min Lee, "The Effect of Sex on the Azoxymethane", Dextran Sulfate Sodium-treated Mice Model of Colon Cancer, 2016, pp.21(4), 271~278[DOI]
- 손희진, "Effect of Estradiol in an Azoxymethane", Dextran Sulfate Sodium-Treated Mouse Model of Colorectal Cancer: Implication for Sex Difference in Colorectal Cancer Development, 2019, pp.51(2), 632~648[DOI]
- Niture SK, "Regulation of Nrf2 : an update", Free Radic Biol Med, 66, pp.36~44 (2014)
- Wu J, "Estrogen increases Nrf2 activity through activation of the PI3K pathway in MCF-7 breast cancer cells", Exp Cell Res, 328, pp.351~360 (2014)
- Caiazza F, "Estrogen receptors and their implications in colorectal carcinogenesis", Front Oncol, 5, pp.19~ (2015)
- Gierisch JM, "Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers : a systematic review", Cancer Epidemiol Biomarkers Prev, 22, pp.1931~1943 (2013)
- Chlebowski RT, "Estrogen plus progestin and colorectal cancer in postmenopausal women", N Engl J Med, 350, pp.991~1004 (2004)
- Kim SE, "Sexand gender-specific disparities in colorectal cancer risk", World J Gastroenterol, 21, pp.5167~5175 (2015)
- Kuiper GG, "Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta", Endocrinology, 138, pp.863~870 (1997)
- Campbell-Thompson M, "Expression of estrogen receptor(ER)subtypes and ERbeta isoforms in colon cancer", Cancer Res, 61, pp.632~640 (2001)
- Wada-Hiraike O, "Role of estrogen receptor beta in colonic epithelium", Proc Natl Acad Sci U S A, 103, pp.2959~2964 (2006)
- Cvoro A, "Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes", J Immunol, 180, pp.630~636 (2008)
- Ospina JA, "Estrogen suppresses IL-1beta-mediated induction of COX-2 pathway in rat cerebral blood vessels", Am J Physiol Heart Circ Physiol, 286, pp.H2010~H2019 (2004)
- Kim W, "15-Deoxy-delta(12, 14)-prostaglandin J2 exerts proresolving effects through nuclear factor E2-related factor 2-induced expression of CD36 and heme oxygenase-1", Antioxid Redox Signal, 27, pp.1412~1431 (2017)
- Paul G, "Analysis of intestinal haem-oxygenase-1(HO-1)in clinical and experimental colitis", Clin Exp Immunol, 140, pp.547~555 (2005)
- Hwang YP, "Mechanism of phytoestrogen puerarin-mediated cytoprotection following oxidative injury : estrogen receptor-dependent up-regulation of PI3K", Akt and HO-1, 2008, pp.233, 371~381
- Yu HP, "Mechanism of the salutary effects of flutamide on intestinal myeloperoxidase activity following trauma-hemorrhage : up-regulation of estrogen receptor-{beta}-dependent HO-1", J Leukoc Biol, 79, pp.277~284 (2006)
- Chi X, "Elevation of HO-1 expression mitigates intestinal ischemia-reperfusion injury and restores tight junction function in a rat liver transplantation model", Oxid Med Cell Longev, 2015, pp.986075~ (2015)
- Ahmed SM, "Nrf2 signaling pathway : pivotal roles in inflammation", Biochim Biophys Acta Mol Basis Dis, 1863, pp.585~597 (2017)
- Park MN, "Insufficient sex description of cells supplied by commercial vendors", Am J Physiol Cell Physiol, 308, pp.C578~C580 (2015)
- DiDonato JA, "NF-kappaB and the link between inflammation and cancer", Immunol Rev, 246, pp.379~400 (2012)
- Hertrampf T, "Tissue-specific modulation of cyclooxygenase-2(Cox-2)expression in the uterus and the v. cava by estrogens and phytoestrogens", Mol Cell Endocrinol, 243, pp.51~57 (2005)
- Poligone B, "Positive and negative regulation of NF-kappaB by COX-2 : roles of different prostaglandins", J Biol Chem, 276, pp.38658~38664 (2001)
- Jaramillo MC, "The emerging role of the Nrf2-Keap1 signaling pathway in cancer", Genes Dev, 27, pp.2179~2191 (2013)
- Khor TO, "Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis", Cancer Res, 66, pp.11580~11584 (2006)
- Khor TO, "Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer", Cancer Prev Res (Phila), 1, pp.187~191 (2008)
- Torday JS, "The sex difference in type II cell surfactant synthesis originates in the fibroblast in vitro", Exp Lung Res, 7, pp.187~194 (1984)
- Alsbeih G, "Gender bias in individual radiosensitivity and the association with genetic polymorphic variations", Radiother Oncol, 119, pp.236~243 (2016)
- Vogel C, "Insights into the regulation of protein abundance from proteomic and transcriptomic analyses", Nat Rev Genet, 13, pp.227~232 (2012)
- Chen CS, "Nrf2-Keap1 antioxidant defense and cell survival signaling are upregulated by 17beta-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells", Neuroendocrinology, 97, pp.232~241 (2013)
- Tao S, "The Nrf2-inducers tanshinone I and dihydrotanshinone protect human skin cells and reconstructed human skin against solar simulated UV", Redox Biol, 1, pp.532~541 (2013)